M3 (STU:4YC) Cyclically Adjusted Revenue per Share: €1.69 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:4YC M3 Inc STU:4YC
69 GF Score
Price €9.40
GF Value €13.94
Valuation Significantly Undervalued
! 3 Warning Signs
View Full Analysis

What is M3 Cyclically Adjusted Revenue per Share?

M3 STU:4YC -6.17% 69 Cyclically Adjusted Revenue per Share is €1.69 as of Mar. 2026. GuruFocus rates STU:4YC with a GF Score™ of 69/100 and a GF Value™ of €13.94 (Significantly Undervalued). The stock has 3 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

M3's adjusted revenue per share for the three months ended in Mar. 2026 was €0.700. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is €1.69 for the trailing ten years ended in Mar. 2026.

During the past 12 months, M3's average Cyclically Adjusted Revenue Growth Rate was 17.00% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 18.10% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 20.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of M3 was 23.30% per year. The lowest was 18.10% per year. And the median was 22.25% per year.

As of today (2026-07-23), M3's current stock price is €9.396. M3's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 was €1.69. M3's Cyclically Adjusted PS Ratio of today is 5.56.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of M3 was 92.80. The lowest was 4.46. And the median was 25.27.


M3  (STU:4YC) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

M3's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=9.396/1.69
=5.56

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of M3 was 92.80. The lowest was 4.46. And the median was 25.27.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


M3 Cyclically Adjusted Revenue per Share Related Terms


M3 Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for M3's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

M3 Cyclically Adjusted Revenue per Share Chart

M3 Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 1.60 1.69

M3 Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.60 1.56 1.62 1.59 1.69

STU:4YC vs VEEV, BTSG, TEM: Cyclically Adjusted Revenue per Share Comparison

For the Health Information Services subindustry, M3's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


M3 Cyclically Adjusted PS Ratio vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, M3's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where M3's Cyclically Adjusted PS Ratio falls into.


STU:4YC
69GF Score
M3 Inc STU:4YC
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

M3 Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, M3's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.7/112.7000*112.7000
=0.700

Current CPI (Mar. 2026) = 112.7000.

M3 Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201606 0.235 98.100 0.270
201609 0.227 98.000 0.261
201612 0.270 98.400 0.309
201703 0.279 98.100 0.321
201706 0.271 98.500 0.310
201709 0.245 98.800 0.279
201712 0.297 99.400 0.337
201803 0.306 99.200 0.348
201806 0.323 99.200 0.367
201809 0.311 99.900 0.351
201812 0.368 99.700 0.416
201903 0.361 99.700 0.408
201906 0.371 99.800 0.419
201909 0.383 100.100 0.431
201912 0.423 100.500 0.474
202003 0.429 100.300 0.482
202006 0.431 99.900 0.486
202009 0.468 99.900 0.528
202012 0.568 99.300 0.645
202103 0.517 99.900 0.583
202106 0.515 99.500 0.583
202109 0.582 100.100 0.655
202112 0.647 100.100 0.728
202203 0.609 101.100 0.679
202206 0.593 101.800 0.656
202209 0.577 103.100 0.631
202212 0.644 104.100 0.697
202303 0.573 104.400 0.619
202306 0.552 105.200 0.591
202309 0.545 106.200 0.578
202312 0.594 106.800 0.627
202403 0.539 107.200 0.567
202406 0.556 108.200 0.579
202409 0.561 108.900 0.581
202412 0.735 110.700 0.748
202503 0.725 111.100 0.735
202506 0.761 111.700 0.768
202509 0.719 112.000 0.723
202512 0.755 113.000 0.753
202603 0.700 112.700 0.700

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of €1.69 mean?
M3 (STU:4YC) has a Cyclically Adjusted Revenue per Share of €1.69 as of Mar. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on M3 and its competitors.
Is M3's Cyclically Adjusted Revenue per Share too high?
M3's current Cyclically Adjusted Revenue per Share is €1.69. Overall, M3 has a GF Score™ of 69/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does M3's Cyclically Adjusted Revenue per Share compare to VEEV and BTSG?
M3's Cyclically Adjusted Revenue per Share of €1.69 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Healthcare Providers & Services company?
A good Cyclically Adjusted Revenue per Share depends on the Healthcare Providers & Services industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on M3 and its competitors. M3's current Cyclically Adjusted Revenue per Share is €1.69. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is M3 stock overvalued right now?
Based on GuruFocus' analysis, M3 (STU:4YC) is currently considered Significantly Undervalued. The stock's GF Value™ is €13.94, compared to a current price of €9.40 — trading 32.6% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is €1.69. M3's overall GF Score™ is 69/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For M3 (STU:4YC), the current Cyclically Adjusted Revenue per Share is €1.69 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is M3 (STU:4YC) Overvalued in 2026?

Based on GuruFocus' analysis, M3 stock appears to be undervalued. The current stock price of €9.40 is trading 32.6% below its estimated GF Value™ of €13.94. GuruFocus considers M3 to be Significantly Undervalued.

Key valuation signals for STU:4YC:

  • Cyclically Adjusted Revenue per Share: €1.69
  • GF Value™: €13.94 vs. price of €9.40 (32.6% below fair value)
  • GF Score™: 69/100 with 3 warning signs

No single metric tells the full story. See the STU:4YC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


M3 Business Description

Other Exchanges MTHRY:USA2413:Japan
Address 1-11-44 Akasaka, Akasaka Intercity, 10th Floor, Minato-ku, Tokyo, JPN, 107-0052
M3 Inc is a Japan-based company engaged in providing medical-related services through internet-based platforms and real-world operations. The company operates six reportable segments: Medical Platform, Evidence Solutions, Career Solutions, Site Solutions, Patient Solutions, and Overseas. Its businesses include online marketing for medical professionals, clinical trial support, human resources services for medical professionals, operational support for medical institutions, and patient support services. The Overseas segment offers similar services internationally, including in the United States, the United Kingdom, China, South Korea, India, France, Germany, and Spain.
69GF Score

Get the complete analysis for STU:4YC

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€9.40
Price
€13.94
GF Value